Growth inhibition and enhanced chemosensitivity induced by down-regulation of aurora-a in human renal cell carcinoma caki-2 cells using short hairpin RNA

Oncology Letters

Volumn 2, Issue 4, 2011, Pages 713-717

  Terakawa, Tomoaki ^a   Miyake, Hideaki ^a   Kumano, Masafumi ^a   Fujisawa, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aurora a; Chemosensitivity; Growth; Renal cell carcinoma

Indexed keywords

AURORA A KINASE; CISPLATIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; PROTEIN BAX; PROTEIN KINASE B; SHORT HAIRPIN RNA;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRAIN CAKI 2; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IC 50; IN VITRO STUDY; KIDNEY CARCINOMA;

EID: 79958029193     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.295     Document Type: Article

References (22)

1. Nigg EA: Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2: 21-32, 2001.
2. Carmena M and Earnshaw WC: The cellular geography of aurora kinase. Nat Rev Mol Cell Biol 4: 842-854, 2003.
3. Warner SL, Bearss DJ, Han H and von Hoff DD: Targeting aurora-2 kinase in cancer. Mol Cancer Ther 2: 589-595, 2003.
4. Fukushige S, Waldman FM, Kimura M, Abe T, Furukawa T, Sunamura M, Kobari M and Horii A: Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosomes Cancer 19: 161-169, 1997.
5. Isola JJ, Kallioniemi OP, Chu LW, Fuqua SA, Hilsenbeck SG, Osborne CK and Waldman FM: Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 147: 905-911, 1995.
6. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR and Sen S: Tumor amplification kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20: 189-193, 1998.
7. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, Schryver B, Flanagan P, Clairvoyant F, Ginther C, Chan CS, Novotny M, Slamon DJ and Plowman GD: A homologue of Drosophila aurora kinase is oncogenic and amplifies in human colorectal cancers. EMBO J 17: 3052-3065, 1998.
8. Drucker BJ: Renal cell carcinoma: current status and future prospects. Cancer Treat Rev 31: 536-545, 2005.
9. Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA and van Kessel AG: Understanding familial and non-familial renal cell cancer. Hum Mol Genet 11: 2489-2498, 2002.
10. Kurahashi T, Miyake H, Hara I and Fujisawa M: Significance of Aurora-A expression in renal cell carcinoma. Urol Oncol 25: 128-133, 2007.
11. Miyake H, Nelson C, Rennie PS and Gleave ME: Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway. Endocrinology 141: 2257-2265, 2000.
12. Miyake H, Hara I, Kurahashi T, Inoue TA, Eto H and Fujisawa M: Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase-PCR. Clin Cancer Res 13: 1192-1197, 2007.
13. Miyake H, Yamanaka K, Muramaki M, Hara I and Gleave ME: Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Neoplasia 7: 171-179, 2005.
14. Tanaka E, Hashimoto Y, Ito T, Okumura T, Kan T, Watanabe G, Imamura M, Inazawa J and Shimada Y: The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma. Clin Cancer Res 11: 1827-1834, 2005.
15. Gritsko TM, Coppola D, Paciga JE, Yang L, Sun M, Shelley SA, Fiorica JV, Nicosia SV and Cheng JQ: Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin Cancer Res 9: 1420-1426, 2003.
16. Guan Z, Wang XR, Zhu XF, Huang XF, Xu J, Wang LH, Wan XB, Long ZJ, Liu JN, Feng GK, Huang W, Zeng YX, Chen FJ and Liu Q: Aurora-A, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells. Cancer Res 67: 10436-10444, 2007.
17. Liu X, Shi Y, Woods KW, Hessler P, Kroeger P, Wilsbacher J, Wang J, Wang JY, Li C, Li Q, Rosenberg SH, Giranda VL and Luo Y: Akt inhibitor a-443654 interferes with mitotic progression by regulating aurora a kinase expression. Neoplasia 10: 828-837, 2008.
18. Cha TL, Chuang MJ, Wu ST, Sun GH, Chang SY, Yu DS, Huang SM, Huan SK, Cheng TC, Chen TT, Fan PL and Hsiao PW: Dual degradation of aurora A and B kinases by the histone deacetylase inhibitor LBH589 induces G2-M arrest and apoptosis of renal cancer cells. Clin Cancer Res 15: 840-850, 2009.
19. Zhou J and Giannakakou P: Targeting microtubules for cancer chemotherapy. Current Med Chem 5: 665-671, 2005.
20. Mazumdar A, Henderson YC, El-Naggar AK, Sen S and Clayman GL: Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma. Head Neck 31: 625-634, 2009.
21. Tanaka E, Hashimoto Y, Ito T, Kondo K, Higashiyama M, Tsunoda S, Ortiz C, Sakai Y, Inazawa J and Shimada Y: The suppression of aurora-A/STK15/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinoma. Clin Cancer Res 13: 1331-1340, 2007.
22. Lee HH, Zhu Y, Govindasamy KM and Gopalan G: Downregulation of Aurora-A overrides estrogen-mediated growth and chemoresistance in breast cancer cells. Endocr Relat Cancer 15: 765-775, 2008.